FamiCord AG (FRA:V3V)

Market Cap	73.21M
Revenue (ttm)	80.64M
Net Income (ttm)	2.58M
Shares Out	n/a
EPS (ttm)	0.15
PE Ratio	28.36
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	75
Average Volume	2,456
Open	4.000
Previous Close	4.040
Day's Range	4.000 - 4.100
52-Week Range	3.700 - 5.250
Beta	n/a
RSI	50.98
Earnings Date	Apr 30, 2025

About FamiCord AG

FamiCord AG engages in the collection, processing, cryopreservation, and storage of stem cells from umbilical cord blood and tissue and postnatal tissue in Germany, Poland, Portugal, and internationally. It operates through Subgroup Vita 34 And Subgroup PBKM segments. The company produces and develops advanced therapies, genetic tests, and analyses for third parties. It also develops products and drugs based on cells, tissues, and blood for medical applications; and produces and manufactures viral vectors and CAR-T cells. In addition, the compa...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1997
• Employees: 745
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: V3V

Financial Performance

In 2023, FamiCord AG's revenue was 77.06 million, an increase of 11.78% compared to the previous year's 68.94 million. Losses were -1.87 million, -93.11% less than in 2022.